Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...

Macworld The Apple Watch Series 10 disappointed some users last year. After hearing about major design changes for a while, ...

Afon Technology has been a leader in diabetes innovation with its GlucowearTM device, the world’s first non-invasive glucose ...

Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

Discover 7 practical, research-backed methods to dramatically lower your diabetes risk and protect your long-term health ...

Biolinq received $100 million in a Series C funding round to bring its wearable for patients with diabetes to market, the ...

Blueberries offer many health benefits, including antioxidants, polyphenols, and more. Here, one editor shares what happened ...

While carbohydrates often dominate discussions about diabetes management, saturated fat and sodium play crucial yet ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...